Asia Pacific Smart Insulin Pens Market By Type (Second Generation - Bluetooth-Enabled, USB Connected; First Generation), Usability (Reusable, Prefilled), End User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings)
Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The Asia Pacific Smart Insulin Pen Market would witness market growth of 11.4% CAGR during the forecast period (2018 – 2024).
Smart insulin pens are used in delivering insulin externally, and as a result, offering better diabetes management system. Insulin pens have gained popularity in the recent years. The demand is due to rapidly rising number of diabetic patients, and cost-effectiveness of the smart insulin pens. In addition, the simple functioning and accurate delivery of appropriate dosing adds to the demand. Nevertheless, some limitations prevail that limit the market growth, such as such as two types of insulin cannot be mixed in an insulin pen, therefore, leading more number of injections. Smart insulin pens are the most effectively developed products as compared to other insulin delivery devices. These pens are easier to use than syringe and are portable, which makes them easy to be used anywhere. One other benefit of the devices is, it allows dialling the dose accurately, and helping people with vision problems administer insulin easily. These are additional factors that drive the growth of the Smart Insulin Pen market.
Based on Product, the market is segmented into Second Generation Pens and First Generation Pens. Based on Usability, the market is segmented into Prefilled and Reusable. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers and Home care settings. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Companion Medical Inc., Digital Medics Ptd Ltd., Eli Lilly and Company, Novo Nordisk A/S, Diamesco Co., Ltd., F. Hoffmann-La Roche AG, Insulet Corporation, Emperra GmbH E-Health Technologies, Jiangsu Delfu medical device Co. Ltd., Bigfoot biomedica.
Scope of the Study
- Second Generation Pens
- USB Connected Smart Insulin Pen
- Bluetooth-Enabled Smart Insulin Pen
- First Generation Pens
By End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Home care settings
- South Korea
- Rest of Asia Pacific
- Companion Medical Inc.
- Digital Medics Ptd Ltd.
- Eli Lilly and Company
- Novo Nordisk A/S
- Diamesco Co., Ltd.
- F. Hoffmann-La Roche AG
- Insulet Corporation
- Emperra GmbH E-Health Technologies
- Jiangsu Delfu medical device Co. Ltd.
- Bigfoot biomedica.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free